Stock BTTX BETTER THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Better Therapeutics, Inc.

Equities

BTTX

US08773T1043

Market Closed - OTC Markets
Other stock markets
 03:51:33 2024-06-04 pm EDT 		5-day change 1st Jan Change
0.0085 USD -12.82% Intraday chart for Better Therapeutics, Inc. +1.19% -95.64%
May. 22 Click Therapeutics, Inc. acquired Assets of Better Therapeutics, Inc.. CI
Mar. 21 Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
AQ
Click Therapeutics, Inc. acquired Assets of Better Therapeutics, Inc..
CI
Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc
CI
Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index
CI
Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from NASDAQ Composite Index
CI
Sector Update: Health Care Stocks Lower Thursday Afternoon
MT
Better Therapeutics to Terminate Employees, Explore Strategic Alternatives; Shares Drop Sharply
MT
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
BU
Better Therapeutics : Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq - Form 8-K
PU
Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
BU
Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
BU
Transcript: Better Therapeutics CEO Interview with RedChip - Form 8-K
PU
Better Therapeutics' Platform Targeting Advanced Liver Disease Receives FDA Breakthrough Device Designation
MT
Better Therapeutics Gets Breakthrough Device Designation For Cognitive Behavioral Therapy Platform
DJ
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
BU
Better Therapeutics, Inc. Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
CI
Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
BU
Better Therapeutics, Inc. announced that it has received $0.25 million in funding
CI
Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone
BU
Better Therapeutics Inc. Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx Is More Effective and Less Costly Than Standard of Care Alone
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BTTX Stock
  4. News Better Therapeutics, Inc.